These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 12141412)
61. Increased risk of venous thromboembolism with a sirolimus-based immunosuppression regimen in lung transplantation. Ahya VN; McShane PJ; Baz MA; Valentine VG; Arcasoy SM; Love RB; Seethamraju H; Garrity E; Alex CG; Bag R; DeOliveira NC; Vigneswaran WT; Charbeneau J; Krishnan JA; Durazo-Arvizu R; Norwick L; Bhorade S J Heart Lung Transplant; 2011 Feb; 30(2):175-81. PubMed ID: 20947384 [TBL] [Abstract][Full Text] [Related]
62. A 12-month single arm pilot study to evaluate the efficacy and safety of sirolimus in combination with tacrolimus in kidney transplant recipients at high immunologic risk. Lee J; Lee JJ; Kim BS; Lee JG; Huh KH; Park Y; Kim YS J Korean Med Sci; 2015 Jun; 30(6):682-7. PubMed ID: 26028917 [TBL] [Abstract][Full Text] [Related]
64. Microangiopathy in kidney and simultaneous pancreas/kidney recipients treated with tacrolimus: evidence of endothelin and cytokine involvement. Burke GW; Ciancio G; Cirocco R; Markou M; Olson L; Contreras N; Roth D; Esquenazi V; Tzakis A; Miller J Transplantation; 1999 Nov; 68(9):1336-42. PubMed ID: 10573073 [TBL] [Abstract][Full Text] [Related]
65. Unusual case report of thrombotic microangiopathy of the small bowel following liver transplantation, a possible immunosuppressant-induced disease with histological and ultrastructural findings. Piscitelli D; Fiore MG; Rossi R; Casiello M; Sanguedolce F ScientificWorldJournal; 2009 Oct; 9():1031-4. PubMed ID: 19802497 [TBL] [Abstract][Full Text] [Related]
66. A successful combination of plasma exchange and intravenous cyclophosphamide in a patient with a refractory thrombotic thrombocytopenic purpura. Zappasodi P; Corso A; Castagnola C; Tajana M; Lunghi M; Bernasconi C Eur J Haematol; 1999 Oct; 63(4):278-9. PubMed ID: 10530421 [No Abstract] [Full Text] [Related]
67. Switching from tacrolimus to sirolimus halts the appearance of new sebaceous neoplasms in Muir-Torre syndrome. Levi Z; Hazazi R; Kedar-Barnes I; Hodak E; Gal E; Mor E; Niv Y; Winkler J Am J Transplant; 2007 Feb; 7(2):476-9. PubMed ID: 17229076 [TBL] [Abstract][Full Text] [Related]
68. Potential strategies for the treatment of plasma exchange-resistant thrombotic thrombocytopenic purpura. Quintini G; Barbera V; Iannitto E; Mariani G Br J Haematol; 2001 May; 113(2):560-2. PubMed ID: 11380435 [No Abstract] [Full Text] [Related]
78. mTOR inhibitors: a myth, a cure for cancer or something in between? Wong G; Chapman JR; Craig JC Am J Transplant; 2012 May; 12(5):1075-6. PubMed ID: 22537261 [No Abstract] [Full Text] [Related]
79. Tacrolimus and sirolimus: when bad things happen to good drugs. Kaplan B; Kirk AD Am J Transplant; 2006 Jul; 6(7):1501-2. PubMed ID: 16827845 [No Abstract] [Full Text] [Related]
80. Tacrolimus-induced thrombotic microangiopathy post-liver transplantation for cryptogenic acute liver failure in an infant. Wujek C; Fishel Ben-Kenan R; Kothari A; Wadera S; Sacco KA Ann Hematol; 2023 Mar; 102(3):687-688. PubMed ID: 36527459 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]